Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2

Jon Arizti-Sanz, Catherine A. Freije, Alexandra C. Stanton, Brittany A. Petros, Chloe K. Boehm, Sameed M. Siddiqui, Bennett Shaw, Gordon Adams, Tinna-Sólveig F. Kosoko-Thoroddsen, Molly Kemball, Jessica N. Uwanibe, Fehintola V. Ajogbasile, Philomena Eromon, Robin Gross, Loni Wronka, Katie Caviness, Lisa E. Hensley, Nicholas H. Bergman, Bronwyn MacInnis, Christian Happi, Jacob E. Lemieux, Pardis C. Sabeti, Cameron Myhrvold

Nature Communications, 2020

Broad Institute, Harvard–MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Harvard University, IIT@MIT, Massachusetts General Hospital, Redeemer's University, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Howard Hughes Medical Institute, Concord Consortium, Princeton University, Critical Path Institute

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with Nature Communications. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

497

Citations

View on Google Scholar

Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2

Abstract

Journal Details

Join JournalsHub

Welcome Back